US Primary Care Physicians' Viewpoints on HPV Vaccination for Adults 27 to 45 Years.

摘要: Introduction: In June 2019, the Advisory Committee on Immunization Practices (ACIP) recommended shared clinical decision making (SCDM) regarding human papillomavirus (HPV) vaccination for adults 27 to 45 years. Our objectives were assess among primary care physicians 1) recent practice HPV 45 years, 2) knowledge of and new SCDM recommendation, 3) attitudes toward anticipated effect recommendation. Methods: From October December we administered an Internet mail survey national networks 494 general internist (GIM) 474 family physician (FP) members American College Physicians Academy Family Physicians, respectively. Results: Response rate was 64% (617/968; GIM, 57%; FP, 71%). Fifty-eight percent aware ACIP recommendation; 42% had but most vaccine very few these patients (73% 0% 22% 1 3). Fifty-five 63% unaware that does not prevent progression existing HPV-related cancers or infections, respectively 57% sure what emphasize when having a conversation about vaccination. A majority reported they will be more likely recommend in 27-to-45-year age range as result Conclusions: are interested recommending 45 years despite routinely it this range. The need education optimal use group.